Effect of preoperative endoscopic biliary drainage on infectious morbidity after pancreatoduodenectomy: a case-control study by E. Lermite et al.
Effect of preoperative endoscopic biliary drainage on
infectious morbidity after pancreatoduodenectomy: a case-
control study
Submitted by Emmanuel Lemoine on Fri, 07/18/2014 - 09:41
Titre Effect of preoperative endoscopic biliary drainage on infectious morbidity afterpancreatoduodenectomy: a case-control study
Type de
publication Article de revue
Auteur Lermite, Emilie [1], Pessaux, Patrick [2], Teyssedou, Carlos [3], Etienne, Sandrine[4], Bréhant, Olivier [5], Arnaud, Jean-Pierre [6]
Editeur Elsevier
Type Article scientifique dans une revue à comité de lecture
Année 2008
Langue Anglais
Date 2008/04
Numéro 4
Pagination 442 - 446
Volume 195
Titre de la
revue The American Journal of Surgery
ISSN 0002-9610
Mots-clés Biliary drainage [7], Infection [8], Morbidity [9], Pancreatoduodenectomy [10]
Résumé en
anglais
BackgroundThe utility of preoperative endoscopic biliary drainage (PEBD) in
jaundiced patients before pancreatoduodenectomy (PD) is still debated. This is in
part due to the heterogeneity of the studied population, including different tumor
location, drainage techniques, and surgical procedures. The aim of the current study
was to report the influence of PEBD on postoperative infectious morbidity of PD.
Materials and Methods Between January 1996 and December 2004, 124 patients
underwent a PD and 28. Twenty-eight (22.6%) of these patients underwent a PEBD.
This group of patients was matched to 28 control patients who underwent PD
without PEBD during the same period. The 2 groups were matched for age, sex,
indication of surgery, and serum bilirubin levels. Results The specific morbidity of
PEBD before surgery was 10.7% (n = 3). The postoperative overall morbidity,
medical morbidity, and surgical morbidity rates were not different between the 2
groups. At the time of surgery, 89.3% (n = 25) of the patients in the PEBD group had
positive bile culture in comparison to 19.4% (n = 4) in the control group (P < .001).
The number of patients with 1 or more infectious complications was higher in the
PEBD group (50%; n = 14) than in the control group (21.4%; n = 6) (P = .05).
Conclusions Before PD, PEBD should be routinely avoided whenever possible in
patients with potentially resectable pancreatic and peripancreatic lesions. In
patients with cholangitis, requiring extensive preoperative assessment (such as liver
biopsy) or neoadjuvant treatment, PEBD might still be indicated.
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